arrow
L

Laura M. Sanz

gsk
H指数:28
被引数:4,239

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of Compound 15 (MMV1581361) as a PfATP4 Inhibitor with Transmission-Blocking Activity and In Vivo Efficacy in a SCID Mouse Model of Malaria

鉴定化合物15 (MMV1581361)为一种具有阻断传播活性和SCID小鼠疟疾模型中体内效果的PfATP4抑制剂

2026-02-110
PRE
Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183
2022-04-2021
OAAI
Discovery and Structure-Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious Antimalarials
2021-08-2619
OAAI
The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance
2021-07-2130
OA
Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as Plasmodium Cytoplasmic Prolyl-tRNA Synthetase Inhibitors
2021-04-3018
OAAI
Substituted Aminoacetamides as Novel Leads for Malaria Treatment
2019-07-036
OAAI
Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine
2019-04-0135
OAAI
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis
2019-03-20111
OAAI
Evaluation of 4-Amino 2-Anilinoquinazolines against Plasmodium and Other Apicomplexan Parasites In Vitro and in a P. falciparum Humanized NOD-scid IL2Rγnull Mouse Model of Malaria

4-氨基-2-苯胺喹唑啉在体外和恶性疟原虫人源化nod-scid IL2Rγnull疟疾小鼠模型中对疟原虫和其他顶复门寄生虫的评估

2019-03-0117
OAAI
Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance

抗疟蛋白酶体抑制剂揭示了亚基间相互作用和抗性适应性成本的附带敏感性

2018-07-0267
OAAI
A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission
2017-09-05105
OAAI
A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance
2017-05-2457
OAAI
Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase
2017-04-26208
OAAI